Susquehanna International Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-115,800
| Closed | -$706K | – | 14450 |
|
|
2021
Q3 | $706K | Buy |
115,800
+60,500
| +109% | +$377K | ﹤0.01% | 8481 |
|
|
2021
Q2 | $455K | Sell |
55,300
-54,100
| -49% | -$460K | ﹤0.01% | 9807 |
|
|
2021
Q1 | $979K | Buy |
109,400
+73,700
| +206% | +$845K | ﹤0.01% | 7802 |
|
|
2020
Q4 | $412K | Sell |
35,700
-26,200
| -42% | -$304K | ﹤0.01% | 8679 |
|
|
2020
Q3 | $644K | Sell |
61,900
-5,100
| -8% | -$62.5K | ﹤0.01% | 7136 |
|
|
2020
Q2 | $881K | Sell |
67,000
-59,500
| -47% | -$617K | ﹤0.01% | 6203 |
|
|
2020
Q1 | $996K | Buy |
126,500
+11,200
| +10% | +$169K | ﹤0.01% | 5415 |
|
|
2019
Q4 | $2.39M | Buy |
115,300
+4,000
| +4% | +$67.5K | ﹤0.01% | 4031 |
|
|
2019
Q3 | $1.52M | Buy |
111,300
+4,500
| +4% | +$53.4K | ﹤0.01% | 4777 |
|
|
2019
Q2 | $1.31M | Buy |
106,800
+17,300
| +19% | +$200K | ﹤0.01% | 5079 |
|
|
2019
Q1 | $1.12M | Sell |
89,500
-94,400
| -51% | -$1.26M | ﹤0.01% | 4833 |
|
|
2018
Q4 | $2.08M | Buy |
183,900
+112,200
| +156% | +$1.76M | ﹤0.01% | 3467 |
|
|
2018
Q3 | $1.34M | Sell |
71,700
-264,500
| -79% | -$6.08M | ﹤0.01% | 4682 |
|
|
2018
Q2 | $8.69M | Buy |
336,200
+76,400
| +29% | +$1.98M | ﹤0.01% | 2085 |
|
|
2018
Q1 | $5.82M | Buy |
259,800
+82,700
| +47% | +$2.02M | ﹤0.01% | 2356 |
|
|
2017
Q4 | $4.43M | Sell |
177,100
-109,100
| -38% | -$2.67M | ﹤0.01% | 2676 |
|
|
2017
Q3 | $6.92M | Buy |
286,200
+142,900
| +100% | +$3.36M | ﹤0.01% | 2137 |
|
|
2017
Q2 | $2.9M | Buy |
143,300
+96,800
| +208% | +$2.02M | ﹤0.01% | 3222 |
|
|
2017
Q1 | $1.25M | Sell |
46,500
-600
| -1% | -$12.3K | ﹤0.01% | 4660 |
|
|
2016
Q4 | $896K | Sell |
47,100
-41,500
| -47% | -$793K | ﹤0.01% | 5767 |
|
|
2016
Q3 | $1.73M | Buy |
88,600
+60,600
| +216% | +$1.03M | ﹤0.01% | 3803 |
|
|
2016
Q2 | $419K | Sell |
28,000
-5,500
| -16% | -$69.1K | ﹤0.01% | 6425 |
|
|
2016
Q1 | $308K | Sell |
33,500
-103,100
| -75% | -$1.25M | ﹤0.01% | 7224 |
|
|
2015
Q4 | $2.63M | Buy |
136,600
+102,300
| +298% | +$1.78M | ﹤0.01% | 3532 |
|
|
2015
Q3 | $510K | Buy |
+34,300
| New | +$805K | ﹤0.01% | 7087 |
|
Susquehanna International Group's FLXN Position: Q4 2021 in Review
Susquehanna International Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 140,764 shares — an estimated $859K sold.
Susquehanna International Group first reported a position in FLXN in Q4 2016 and held it in 13 quarters. The position peaked at $2.51M in Q4 2017. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Susquehanna International Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Susquehanna International Group sold 140,764 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $859K.
- Susquehanna International Group first reported a position in Flexion Therapeutics, Inc. in Q4 2016 and held it in 13 quarters.
- Susquehanna International Group's Flexion Therapeutics, Inc. position peaked at $2.51M in Q4 2017.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.